CG
CORZ icon

Covalis (Gibraltar)’s Core Scientific CORZ Stock Holding History

Covalis (Gibraltar)’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.78M Sell
382,367
-900,232
-70% -$21.2M 36.11% 2
2026
Q1 		$19.2M Sell
1,282,599
-797,951
-38% -$13.6M 85.14% 1
2025
Q4 		$30.3M Buy
+2,080,550
New +$36.3M 24.14% 2

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Covalis (Gibraltar)'s CORZ Position: Q2 2026 in Review

Covalis (Gibraltar) reduced its Core Scientific (CORZ) stake by 70% in Q2 2026, selling an estimated $21.2M and leaving 382,367 shares worth $9.78M. The position accounts for 36.11% of the portfolio, ranked #2.

Covalis (Gibraltar) first reported a position in CORZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $30.3M in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Covalis (Gibraltar) held 382,367 shares of Core Scientific worth $9.78M as of Q2 2026.
  • Covalis (Gibraltar) sold 900,232 Core Scientific shares in Q2 2026, an estimated $21.2M.
  • Core Scientific made up 36.11% of Covalis (Gibraltar)'s portfolio in Q2 2026, its #2 holding.
  • Covalis (Gibraltar) first reported a position in Core Scientific in Q4 2025 and has held it in 3 quarters since.
  • Covalis (Gibraltar)'s Core Scientific position peaked at $30.3M in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Covalis (Gibraltar)'s 13F filing for Q2 2026, filed 13 Aug 2026.